Author

Karley White

National Institutes of Health

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1 Approach:statistical model· 1

Frequent Co-Authors

Alexei V. LobanoviD· 1 shared Daoud M. MeerzamaniD· 1 shared David A. WinkiD· 1 shared Donna M. Voeller· 1 shared Lisa A. RidnouriD· 1 shared Maggie CamiD· 1 shared Manjari KunduiD· 1 shared Qingrong CheniD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Alexei V. LobanovORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

TRAIL-induced cytokine production via NFKB2 pathway promotes neutrophil chemotaxis and immune suppression in triple negative breast cancers

Manjari Kundu, Yoshimi Endo Greer, Alexei V. Lobanov, Lisa A. Ridnour, Renee Nicole Donahue, Yeap Ng, Shashi Ratnayake, Karley White, Donna M. Voeller, Sarah Weltz, Qingrong Chen, Stephen Lockett, Maggie Cam, Daoud M. Meerzaman, David A. Wink, , Stanley Lipkowitz

This study shows TRAIL treatment of TNBC cells activates the NFKB2 pathway, leading to cytokine production that enhances neutrophil chemotaxis and immune suppression.

Cancer Letters · Apr 6, 2025Peer-reviewedCancer Biology